## AMCR: Amcor plc - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.55 indicates fundamental undervaluation. Caution: momentum weakening (-4.5% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($7.98)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Dir Carter Files To Sell 6,058 Of Amcor PLC [AMCR]**
- Source: TradingView | 20251204T032501 | Neutral | Relevance: 100%
- Susan K. Carter, a Director of Amcor PLC (AMCR), filed a Form 144 on December 3, 2025, indicating her intention to sell 6,058 restricted securities. The sale is proposed to occur with Fidelity Brokerage Services around the same date. The Washington Service provides insider trading analysis and data services related to such filings.

**2. Amcor plc (NYSE: AMCR) director reports RSU conversion and 19,907-unit equity award**
- Source: Stock Titan | 20251203T160900 | Neutral | Relevance: 100%
- An Amcor plc director, Lucrece Foufopoulos-De Ridder, converted 14,279 restricted stock units (RSUs) into ordinary shares and received a new grant of 19,907 RSUs. Following the conversion, the director beneficially owns 43,802 ordinary shares directly. The newly granted RSUs are scheduled to vest on December 1, 2026.

**3. AMCR SEC Filings - Amcor Plc 10-K, 10-Q, 8-K Forms**
- Source: Stock Titan | 20251204T032501 | Neutral | Relevance: 100%
- This article provides a comprehensive overview of Amcor Plc's SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K material event filings, and insider trading Form 4s. It details several specific filings from late 2025 related to AGM results, quarterly earnings, proxy statements, and numerous insider transactions involving stock sales, option exercises, and RSU grants by executives and directors. The page emphasizes Stock Titan's AI-powered tools for simplifying these complex documents for investors and traders.

**4. [Form 4] Amcor plc Insider Trading Activity**
- Source: Stock Titan | 20251203T160700 | Neutral | Relevance: 100%
- An Amcor plc director, James T Jr. Glerum, reported insider trading activity via a Form 4 filing. The filing details the vesting of 9,317 restricted stock units, which converted into ordinary shares, and the grant of 19,907 new restricted stock units. These transactions adjusted the director's direct and indirect holdings of Amcor plc shares.

**5. Edgestream Partners L.P. Has $6.12 Million Stock Position in Amcor PLC $AMCR**
- Source: MarketBeat | 20251203T094650 | Somewhat-Bullish | Relevance: 100%
- Edgestream Partners L.P. significantly increased its stake in Amcor PLC (NYSE:AMCR) by 29.9% in the second quarter, bringing its total holdings to $6.12 million. Other institutional investors also boosted their positions, with overall institutional ownership reaching 45.14%. Analysts have issued a "Moderate Buy" rating for Amcor with an average price target of $10.91, alongside the company's recent dividend increase.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 22 ($2.26M) |
| Sells | 13 ($0.14M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 34.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 1 |

**Top Holders:**
- Blackrock Inc.: 6.7% (-4.6%)
- State Street Corpora: 6.0% (+7.2%)
- Vanguard Group Inc: 4.8% (+1.1%)
- M&G Plc: 4.7% (+26.6%)
- Charles Schwab Inves: 3.5% (+1.6%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-4.5% 5d) with bearish MACD, trend may be turning.
2. Long-term trend broken: trading 7.7% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.55 indicates undervaluation relative to growth. Forward P/E 9.3x attractive for 11% earnings growth. Insider buying signal ($2.3M), management confidence. Institutional flow bullish (8 buying vs 1 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.2B |
| Beta | 0.68 |
| 52W Range | $7.67 - $10.45 |
| Short Interest | 4.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.55 |
| Forward P/E | 9.3 |
| Current P/E | 10.3 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.0% to -2.5% (-4.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 6.5pp (needs >4.0% for momentum thesis). Below SMA200 (0.92x), long-term trend not supportive. RSI neutral at 48. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.48% (CS: 27) | Weak |
| RSI_14 | 47.5 | Neutral |
| MACD Histogram | -0.02 | Bearish |
| vs SMA20 | 0.985x | Below |
| vs SMA50 | 1.012x | Above |
| vs SMA200 | 0.923x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $8.32
- **Stop Loss:** $7.98 (4.1% risk)
- **Target:** $9.00 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 2941
- **Position Value:** $24,469.12
- **Portfolio %:** 24.47%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-02-03 (Est: $0.17)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.18 | $0.19 | +4.9% |
| 2025Q2 | $0.22 | $0.20 | -7.2% |
| 2025Q1 | $0.18 | $0.18 | -1.3% |
| 2024Q4 | $0.16 | $0.16 | +2.2% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*